Salvia, salvinorins & derivatives
Barnes & Snow (2012). Analysis of Salvinorin A in plants, water, and urine using solid-phase microextraction-comprehensive two-dimensional gas chromatography-time of flight mass spectrometry. Journal of Chromatography.
Butelman et al. (2012). Behavioral effects and central nervous system levels of the broadly available κ-agonist hallucinogen salvinorin A are affected by P-glycoprotein modulation in vivo. The Journal of Pharmacology and Experimental Therapeutics.
Willard, McGuffin & Smith (2012). Forensic analysis of Salvia divinorum using multivariate statistical procedures. Part I: discrimination from related Salvia species. Analytical and Bioanalytical Chemistry.
Willard, McGuffin & Smith (2012). Forensic analysis of Salvia divinorum using multivariate statistical procedures. Part II: association of adulterated samples to S. divinorum. Analytical and Bioanalytical Chemistry.
Dueweke (2013). Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 3: what are the clinical features of Salvia divinorum toxicity? Emergency Medicine Journal.
Gutierrez & Cooper (2014). Investigating correlates of synthetic marijuana and Salvia use in light and intermittent smokers and college students in a predominantly Hispanic sample. Experimental and Clinical Psychopharmacology.
Hamidpour et al. (2014). Chemistry, pharmacology, and medicinal property of sage (salvia) to prevent and cure illnesses such as obesity, diabetes, depression, dementia, lupus, autism, heart disease, and cancer. Journal of Traditional and Complementary Medicine.
Lin et al. (2014). Quantitative determination of salvinorin A, a natural hallucinogen with abuse liability, in Internet-available Salvia divinorum and endemic species of Salvia in Taiwan. Journal of Food and Drug Analysis.